Search

Your search keyword '"Akiyama, Tetsu"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Akiyama, Tetsu" Remove constraint Author: "Akiyama, Tetsu" Database Complementary Index Remove constraint Database: Complementary Index
83 results on '"Akiyama, Tetsu"'

Search Results

1. Increased prevalence of zinc hypersensitivity in patients with primary Sjögren syndrome: A case–control study.

2. PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer.

3. The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen.

4. Hypoxia-inducible factor 1α induces osteo/odontoblast differentiation of human dental pulp stem cells via Wnt/β-catenin transcriptional cofactor BCL9.

5. Dysbiosis of Oral Microbiota Associated with Palmoplantar Pustulosis.

6. Higher Prevalence of Nickel and Palladium Hypersensitivity in Patients with Ulcerative Colitis.

7. Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome.

9. Sp5 negatively regulates the proliferation of HCT116 cells by upregulating the transcription of p27.

11. MYU, a Target lncRNA for Wnt/c-Myc Signaling, Mediates Induction of CDK6 to Promote Cell Cycle Progression.

12. The RNA Binding Protein Mex-3B Is Required for IL-33 Induction in the Development of Allergic Airway Inflammation.

13. Requirement of DLG1 for Cardiovascular Development and Tissue Elongation during Cochlear, Enteric, and Skeletal Development: Possible Role in Convergent Extension.

14. Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.

15. 5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Complex.

17. Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an in vitro cytokine response assay.

18. Differences in the localization of the adenomatous polyposis coli- Asef/ Asef2 complex between adenomatous polyposis coli wild-type and mutant cells.

19. Novel mouse model for Gardner syndrome generated by a large-scale N-ethyl- N-nitrosourea mutagenesis program.

20. The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels.

21. Phosphoproteome of Human Glioblastoma Initiating Cells Reveals Novel Signaling Regulators Encoded by the Transcriptome.

22. A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis.

23. The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in ApcMin/+mice.

24. Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApCMin/+ mice with natural ligands.

25. Gene set-based module discovery in the breast cancer transcriptome.

27. Ligand-dependent interaction between estrogen receptor α and adenomatous polyposis coli.

28. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by β-catenin/TCF.

29. Novel clusters of highly expressed genes accompany genomic amplification in breast cancers

30. Requirement of the tumour suppressor APC for the clustering of PSD-95 and AMPA receptors in hippocampal neurons.

31. PX-RICS, a novel splicing variant of RICS, is a main isoform expressed during neural development.

32. Immunohistochemical expression of the β-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.

33. Up-regulation of a BCL9-related β-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma.

34. Role of the Rho GTPase-activating protein RICS in neurite outgrowth.

35. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli.

36. Viral FLIP Enhances Wnt Signaling Downstream. of Stabilized β-Catenin, Leading to Control of Cell Growth.

37. Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs.

38. Cloning of novel LERGU mRNAs in GPR30 3′ untranslated region and detection of 2 bp-deletion polymorphism in gastric cancer.

39. DKK1, a negative regulator of Wnt signaling, is a target of theß-catenin/TCF pathway.

40. MFB-1, an F-box-type ubiquitin ligase, regulates TGF-β signalling.

41. The Wnt/β-catenin pathway directs neuronal differentiation of cortical neural precursor cells.

42. DREG, a developmentally regulated G protein-coupled receptor containing two conserved proteolytic cleavage sites.

43. Anteriorization of neural fate by inhibitor of Β-catenin and T cell factor (ICAT), a negative regulator of Wnt signaling.

44. Mutated APC and Asef are involved in the migration of colorectal tumour cells.

46. The SH3, HOOK and guanylate kinase-like domains of hDLG are important for its cytoplasmic localization.

47. SPAL, a Rap-specific GTPase activating protein, is present in the NMDA receptor-PSD-95 complex in the hippocampus.

48. Identification of a link between the tumour suppressor APC and the kinesin superfamily.

49. The hDLG-associated protein DAP interacts with dynein light chain and neuronal nitric oxide synthase.

50. The colorectal tumour suppressor APC is present in the NMDA-receptor-PSD-95 complex in the brain.

Catalog

Books, media, physical & digital resources